Activity of STI571 in chronic myelomonocytic leukemia with a platelet-derived growth factor beta receptor fusion oncogene.
about
Recent advances in diagnosis, molecular pathology and therapy of chronic myelomonocytic leukaemiaNCCN Clinical Practice Guidelines in Oncology: myelodysplastic syndromes.Patients with myeloid malignancies bearing PDGFRB fusion genes achieve durable long-term remissions with imatinib.Protein kinase inhibitors substantially improve the physical detection of T-cells with peptide-MHC tetramersImatinib mesylate in the treatment of chronic myeloid leukaemia.Mutational spectrum analysis of chronic myelomonocytic leukemia includes genes associated with epigenetic regulation: UTX, EZH2, and DNMT3A.Achievement of complete remission predicts outcome of allogeneic haematopoietic stem cell transplantation in patients with chronic myelomonocytic leukaemia. A study of the Chronic Malignancies Working Party of the European Group for Blood and MarrowTargeting mutated tyrosine kinases in the therapy of myeloid leukaemias.Molecular classification and pathogenesis of eosinophilic disorders: 2005 update.Modern diagnosis and treatment of primary eosinophilia.Chronic myelomonocytic leukemia: Forefront of the field in 2015.Roles for deregulated receptor tyrosine kinases and their downstream signaling molecules in hematologic malignancies.Myelodysplastic syndromes: clinical practice guidelines in oncology.Prognostic molecular markers in myelodysplastic syndromes.Autocrine PDGF stimulation in malignancies.Advances in molecular diagnostics of myeloproliferative disorders.PDGFRᵝ-Rearranged Myeloid Neoplasm with Marked Eosinophilia in a 37-Year-Old Man; And a Literature Review.Metabolic characterization of imatinib-resistant BCR-ABL T315I chronic myeloid leukemia cells indicates down-regulation of glycolytic pathway and low ROS production.Nilotinib hampers the proliferation and function of CD8+ T lymphocytes through inhibition of T cell receptor signallingPDGFRB-rearranged T-lymphoblastic leukemia/lymphoma occurring with myeloid neoplasms: the missing link supporting a stem cell origin.Chronic myeloproliferative disorders with rearrangement of the platelet-derived growth factor alpha receptor: a new clinical target for STI571/Glivec.KIAA1509 is a novel PDGFRB fusion partner in imatinib-responsive myeloproliferative disease associated with a t(5;14)(q33;q32).Marked response to imatinib mesylate in a patient with platelet-derived growth factor receptor beta-associated acute myeloid leukemia.Activity of azacitidine in chronic myelomonocytic leukemia.Platelet-derived growth factor beta receptor (PDGFRB) gene is rearranged in a significant percentage of myelodysplastic syndromes with normal karyotype.
P2860
Q28307278-5A535731-2256-4AE4-9BF6-FE1AEB064E41Q33393647-C053B1E4-7312-4EF6-9BF1-9ADB7D256D70Q33718814-840C2EB1-4DAD-48B2-A303-006284D28714Q34641211-7A6D902F-CCA3-4BEE-8BC7-F4BF0493CF8CQ35143966-275BE583-2427-4570-9606-1ED72857A3C8Q35346433-F8643E68-31A2-4C3E-9EAB-76ABF683E478Q35714782-998298DC-826A-462B-BC28-E37A37897884Q35782893-36A953F2-9C58-4170-8E68-33C004F69D03Q36182741-92EBF725-2EAE-4351-9C64-77B295013F32Q36182754-BBF06A44-F6E7-4C44-B23F-95B8EEF5BFA1Q36876853-AC6B0D69-E965-494A-8A1E-33D6406BB696Q37051428-22A4ED9B-CCA8-4786-8DAC-CC4792A6856EQ37723847-D303FF9A-8395-4321-858F-5370832617EBQ37810120-CDD56F1F-1BC2-405C-9F9D-ACEF35C77677Q38003387-81B8E213-3EF5-4E8A-B577-3BF50C4761F7Q38089228-5D9CDBC4-CAF1-4C85-ADDC-42F234C77DF8Q39139762-93A5AD60-62EB-4822-B5D1-1589C238232DQ40015371-6259FC3F-22F4-407A-BDAE-970757127D12Q41963473-752D4D43-C9F0-4AC1-BB33-0077C922CDCFQ43135301-7D8860AC-0105-4ECC-8089-0E6559971F74Q44566239-673BEB05-92E8-4108-B63C-A356F775F3F8Q45117346-00FE9955-3898-402A-B594-0507EDFB0005Q51246186-B9B2EF1C-78D5-461C-9712-258BDA72DE97Q53152113-7984289D-8910-4478-8D33-772A35DEC9DFQ54720518-E53B7BF9-8792-4CD8-8414-0F63ED7BFC05
P2860
Activity of STI571 in chronic myelomonocytic leukemia with a platelet-derived growth factor beta receptor fusion oncogene.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh
2002年學術文章
@zh-hant
name
Activity of STI571 in chronic ...... beta receptor fusion oncogene.
@en
Activity of STI571 in chronic ...... beta receptor fusion oncogene.
@nl
type
label
Activity of STI571 in chronic ...... beta receptor fusion oncogene.
@en
Activity of STI571 in chronic ...... beta receptor fusion oncogene.
@nl
prefLabel
Activity of STI571 in chronic ...... beta receptor fusion oncogene.
@en
Activity of STI571 in chronic ...... beta receptor fusion oncogene.
@nl
P2093
P1433
P1476
Activity of STI571 in chronic ...... beta receptor fusion oncogene.
@en
P2093
Cynthia E Dunbar
John Barrett
Kristin E Meade
Magnus K Magnusson
Ryotaro Nakamura
P304
P356
10.1182/BLOOD-2002-01-0165
P407
P577
2002-08-01T00:00:00Z